Categories: National

Hyderabad’s Pharma Co. Aptuit Laurus bags Rs.200 Cr Investment

Fidelity Growth Partners India, the India-focused private equity arm of Fidelity Worldwide, has invested around Rs 200 crore in Hyderabad-based pharmaceutical company, Aptuit Laurus. The company manufactures active pharmaceutical ingredients (APIs) for anti-retroviral (HIV-AIDS), oncology, nutraceutical and several other products with a customer base spanning in India and abroad. The company also has a growing contract research and manufacturing business offering, which works with several global pharma companies, the release said.

“In a short span of time, Laurus has established global leadership positions in its key product offerings, built world-class infrastructure and serves a top-tier customer base. The company continues to drive innovation in its strong product pipeline of difficult-to-make molecules, which, we believe will help it build a long-term defensible business,” Senior Managing Director at FIL Capital Advisors (India), Raj Dugar said. However, the company didn’t disclose the stake it will get in the pharma company after the announced investment.

Referring to this equity investment, Chief Executive Officer of Laurus, Chava Satyanarayana said, “Laurus has built a strong reputation in product development and manufacturing and a track record of high-quality products to its customers. We are glad to partner with FGPI in this phase of our growth, where, we will seek to continue the thrust on innovation and manufacturing excellence in offering cost effective products and services.”

The Pharma Times News Bureau

Recent Posts

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

20 hours ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

20 hours ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

2 days ago

From Pain to Relief: How endoscopic spine surgery enhances patient outcomes

By DR UMESH SRIKANTHA, Senior Consultant - Neurosurgery, Head of Spine Services, Aster RV Hospital …

3 days ago

Henkel India Unveils Dedicated Researchers’ World Lab in India

Pune, November 11, 2024: Henkel Adhesives Technologies India Private Limited (Henkel India) announces the opening…

3 days ago